Kidiamix G

Amino acid solution, the active ingredient in Kidiamix G, is a Amino acid solution presented as a solution for injection for parenteral use. It provides essential and non‑essential amino acids to patients who cannot receive enteral nutrition. GNH USA supplies Kidiamix G as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kidiamix G, an amino acid solution for parenteral nutrition, supports patients who cannot receive enteral feeding. - Parenteral nutrition: provides a complete amino acid profile to maintain protein synthesis in patients unable to eat orally or enterally. - Post‑operative care: supplies essential amino acids to aid recovery after major surgery. - Critical care/trauma: helps maintain nitrogen balance in severely ill or injured patients.

Kidiamix G may be associated with infusion‑related reactions and metabolic changes.

Common Side Effects: - Phlebitis at infusion site: mild inflammation of the vein used for administration. - Mild hypernatremia: slight increase in serum sodium levels. - Transient rise in blood urea nitrogen: temporary elevation reflecting protein metabolism. - Mild metabolic alkalosis: slight shift in acid‑base balance.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Severe hyperammonemia: dangerous accumulation of ammonia in the blood. - Electrolyte disturbances (e.g., hyperkalemia): significant changes in serum electrolytes. - Catheter‑related infection: infection at the intravenous access site.

Kidiamix G requires careful monitoring in specific clinical situations. - Renal impairment: monitor renal function and adjust amino acid load as needed. - Liver disease: watch for ammonia accumulation and adjust therapy accordingly. - Electrolyte imbalance: regularly check serum electrolytes during treatment. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk to the fetus or infant. - Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kidiamix G can interact with certain medications and solutions.

Major Interactions (Avoid): - Concurrent high‑dose nitrogenous waste products: may exacerbate hyperammonemia. - Incompatible IV solutions (e.g., calcium‑containing solutions): can precipitate and cause emboli.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase loss of electrolytes, requiring close monitoring. - Insulin therapy: amino acids stimulate insulin release, potentially affecting glucose control. - Other parenteral nutrition components: balance of dextrose and lipids should be coordinated to avoid metabolic overload.